PEG interferon (combined) · patients on HD with HCV infection
High showed no clear difference in PEG interferon (combined) compared with low dose pegylated interferon alpha‐2a or alpha‐2b (moderate certainty).
3 findings from 1 review
RR 4.3 [0.76, 24.33]
2 studies · 97 participants
Moderate
RR 1.12 [0.4, 2.21]
1 study · 43 participants
Low
RR 1.05 [0.61, 1.83]
2 studies · 97 participants
Moderate
End‐of‐treatment response · patients on HD with HCV infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment discontinuation · patients on HD with HCV infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · patients on HD with HCV infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · patients on HD with HCV infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
50% or greater reduction in seizure frequency · people with focal seizures
High probably leads to higher 50% reduction in seizure frequency (responders) compared with low stimulation (moderate certainty).
1 finding from 1 review
Treatment withdrawal · people with focal seizures
High showed no clear difference in withdrawals compared with low stimulation (low certainty).
1 finding from 1 review
Voice Alteration or Hoarseness · people with focal seizures
High probably leads to higher voice alteration or hoarseness compared with low stimulation (moderate certainty).
1 finding from 1 review
Cough · people with focal seizures
High showed no clear difference in cough compared with low stimulation (moderate certainty).
1 finding from 1 review
Dyspnea · people with focal seizures
High may leads to higher dyspnoea compared with low stimulation (low certainty).
1 finding from 1 review
Pain · people with focal seizures
High showed no clear difference in pain compared with low stimulation (moderate certainty).
1 finding from 1 review
Paraesthesia · people with focal seizures
High showed no clear difference in paraesthesias compared with low stimulation (moderate certainty).
1 finding from 1 review
All‐cause mortality – deaths · adults with or without existing CVD
High showed no clear difference in all‐cause mortality – deaths compared with low long‐chain omega‐3 fats (high certainty).
1 finding from 1 review
All‐cause mortality – deaths · adults with or without existing CVD
High showed no clear difference in all‐cause mortality – deaths compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · adults with or without existing CVD
High showed no clear difference in cardiovascular mortality – cardiovascular deaths compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).
1 finding from 1 review
Cardiovascular events · adults with or without existing CVD
High showed no clear difference in cardiovascular events compared with low alpha‐linolenic acid omega‐3 fats (low certainty).
1 finding from 1 review
Coronary heart disease mortality – CHD deaths · adults with or without existing CVD
High showed no clear difference in coronary heart disease mortality – CHD deaths compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).
1 finding from 1 review
CHD events · adults with or without existing CVD
High showed no clear difference in coronary heart disease events compared with low alpha‐linolenic acid omega‐3 fats (low certainty).
1 finding from 1 review
Stroke · adults with or without existing CVD
It is very uncertain whether high changes stroke compared with low alpha‐linolenic acid omega‐3 fats (very low certainty).
1 finding from 1 review
Arrhythmias · adults with or without existing CVD
High probably leads to lower arrhythmias compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).
1 finding from 1 review